Having safe and effective vaccines a full year since the first reported cases of COVID-19 is a historic scientific achievement. It has shifted the conversation from “if” we will see an end to the pandemic to “when.”
But COVID-19 will not end with just a vaccine. It ends when everyone, everywhere has access to it. If the virus remains unchecked anywhere in the world, it will continue to move across borders, mutate, and drastically impact the global economy. Prioritizing the...
Vaccines
The world’s richest countries are on track to accumulate over 1 billion more doses of COVID-19 vaccines than they need to fully vaccinate all their citizens, according to new analysis from ONE’s Policy team. Meanwhile, the rest of the world has only been able to secure 2.5 billion doses of the most promising vaccines — leaving billions of people with little hope of receiving a vaccine this year. These excess doses purchased by rich countries alone would be sufficient...
A roundup of the latest news, stats, and analysis of COVID-19’s impact in Africa. Read on for more about which country has reached 1 million cases and Tanzania’s continued pandemic silence. But first, how to prevent a vaccine apartheid.
Top news
Catastrophic moral failure: UNAIDS Director Winnie Byanyima recently called out the emerging ‘“Vaccine Apartheid” as rich countries hoard vaccine supplies. WHO Director General Tedros said “We are on the brink of a catastrophic moral failure.” The Economic Intelligence Unit predicts...
Less than a year since the COVID-19 pandemic started, AstraZeneca, Pfizer/BioNTech, and Moderna have created safe and effective vaccines against the virus, and some nations have begun vaccinating their citizens. Although this is great news and a major scientific achievement, the work isn’t done, and we’re seeing some signs that this accomplishment could be undermined by a failure to get the vaccine everywhere.
The pandemic won’t end with just a vaccine, but when there is global access to it and...
With Pfizer/BioNTech, Moderna, and AstraZeneca all announcing this month that their vaccine candidates for COVID-19 are proving to be highly effective in clinical trials, the world is closer to finding a safe and effective vaccine to fight the COVID-19 pandemic. However, the pandemic will not end with a vaccine, but when everyone, everywhere has equal access to it.
That’s why we launched our Vaccine Access Test in September. The Test provides the framework to answer one important question: Are the...
The world is racing to find safe and effective vaccines against COVID-19, and world leaders are making deals for promising COVID-19 vaccine candidates and speaking about the need for vaccine equity. As this happens, we want them to know that we’re watching. That’s why in September, ONE launched the Vaccine Access Test.
The Test provides the framework to answer one question: Are the actions taken by world leaders and players moving us closer to or further from an equitable outcome...
To ensure that the world responds effectively to COVID-19 and the challenges it has presented, world leaders, companies, and individuals need to come together in a single response effort — a global pandemic of this magnitude demands a global response.
Finding an effective vaccine is a key part of a global response plan. But that is only half the battle.
After an effective vaccine for COVID-19 becomes available, world leaders must come together to ensure there is equitable access to a...